Melissa B. Davis

3.5k total citations
84 papers, 1.2k citations indexed

About

Melissa B. Davis is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Melissa B. Davis has authored 84 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 35 papers in Oncology and 22 papers in Genetics. Recurrent topics in Melissa B. Davis's work include Cancer Genomics and Diagnostics (20 papers), BRCA gene mutations in cancer (15 papers) and Breast Cancer Treatment Studies (15 papers). Melissa B. Davis is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), BRCA gene mutations in cancer (15 papers) and Breast Cancer Treatment Studies (15 papers). Melissa B. Davis collaborates with scholars based in United States, United Kingdom and Ghana. Melissa B. Davis's co-authors include Lisa A. Newman, Rachel Martini, Clayton Yates, A.E. Robertson, Michael Bender, Ginger E. Carney, Brittany D. Jenkins, Windy Dean‐Colomb, Shalini Srivastava and Qinghua He and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Melissa B. Davis

82 papers receiving 1.2k citations

Peers

Countries citing papers authored by Melissa B. Davis

Since Specialization

Citations

This map shows the geographic impact of Melissa B. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa B. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa B. Davis more than expected).

Fields of papers citing papers by Melissa B. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa B. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa B. Davis. The network helps show where Melissa B. Davis may publish in the future.

Co-authorship network of co-authors of Melissa B. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa B. Davis. A scholar is included among the top collaborators of Melissa B. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa B. Davis. Melissa B. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiotoxicity of breast cancer drug treatments 2025 ·Translational Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mansour Alsaleem, Emad A. Rakha, Sheeba Irshad, Melissa B. Davis, Jennie N. Jeyapalan, Nigel P. Mongan, Catrin S. Rutland	2
2	Precision oncology and genetic ancestry: The science behind population-based cancer disparities 2025 ·Cancer Cell ·Melissa B. Davis, (unknown)	3
3	Abstract 7467: Multi-omics analysis reveals high chronic inflammation in African Americans compared to Native African Men with prostate cancer 2024 ·Cancer Research ·(unknown), Ezra Baraban, Tamara L. Lotan, (unknown), Emmanuel S. Antonarakis, Moray J. Campbell, Melissa B. Davis, Michael Dixon, Isaac Kim, Stefan Ambs, Rick A. Kittles, Adam B. Murphy, Clayton Yates	0
4	Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling 2023 ·Cancers ·(unknown), Brittany D. Jenkins, (unknown), Sandeep K. Singhal, Kevin Gardner, Ahmad Bin Salam, Anghesom Ghebremedhin, Jason White, Iqbal Mahmud, Rachel Martini, Deepa Bedi, Huixian Lin, Jacqueline Jones, (unknown), Windy Dean‐Colomb, William E. Grizzle, Honghe Wang, Melissa B. Davis, Clayton Yates	3
5	Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), Yalei Chen, Jennifer L. Marti, Rache M. Simmons, Alexander Swistel, Jessica Bensenhaver, Melissa B. Davis, Lisa A. Newman	5
6	Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment 2023 ·Brain Communications ·Kiel M. Telesford, (unknown), Marcel Mettlen, Melissa B. Davis, Lindsay G. Cowell, Rick A. Kittles, Timothy Vartanian, Nancy Monson	1
7	Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors 2023 ·JAMA Network Open ·Hari S. Iyer, Nur Zeinomar, Angela R. Omilian, (unknown), Melissa B. Davis, Coral Omene, Karen Pawlish, Kitaw Demissie, Chi‐Chen Hong, Song Yao, Christine B. Ambrosone, Elisa V. Bandera, Bo Qin	11
8	Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma 2023 ·Neuro-Oncology ·Evan Noch, (unknown), (unknown), (unknown), Yuqing Qiu, Hiranmayi Ravichandran, Junbum Kim, André F. Rendeiro, Melissa B. Davis, Olivier Elemento, David J. Pisapia, Kevin Zhai, H. Carl LeKaye, Jason A. Koutcher, Patrick Y. Wen, Keith L. Ligon, Lewis C. Cantley	18
9	Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana 2022 ·The Oncologist ·Lewis R. Roberts, Brian M. Rivers, Clayton Yates, Lisa A. Newman, (unknown), Melissa B. Davis, (unknown), Alex A. Adjei, (unknown), Baffour Awuah	7
10	Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility 2022 ·Cancer Discovery ·Rachel Martini, (unknown), (unknown), Melissa B. Davis	6
11	MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans 2022 ·Scientific Reports ·Anusha Angajala, (unknown), Aliyu Muhammad, (unknown), (unknown), (unknown), Honghe Wang, Moray J. Campbell, Rachel Martini, (unknown), Andrea G. Kahn, Deepa Bedi, Melissa B. Davis, Ming Tan, Windy Dean‐Colomb, Clayton Yates	4
12	Are we there yet? A machine learning architecture to predict organotropic metastases 2021 ·BMC Medical Genomics ·(unknown), (unknown), Yi Zhou, Shannon Quinn, Melissa B. Davis, Andrea Sboner, Mandi M. Murph, Jonathan Arnold	1
13	Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic 2021 ·Current Breast Cancer Reports ·Lisa A. Newman, Laura Fejerman, Tuya Pal, Eralda Mema, Geraldine McGinty, Alex Cheng, Mia Levy, Adeyiza O. Momoh, Melissa A. Troester, Bryan P. Schneider, (unknown), Melissa B. Davis, Kemi Babagbemi, Kelly K. Hunt	11
14	Cancer microenvironment and genomics: evolution in process 2021 ·Clinical & Experimental Metastasis ·Stanley P. L. Leong, Isaac P. Witz, Orit Sagi‐Assif, Sivan Izraely, Jonathan P. Sleeman, Brian Piening, Bernard A. Fox, Carlo Bifulco, Rachel Martini, Lisa A. Newman, Melissa B. Davis, Lauren Sanders, David Haussler, Olena M. Vaske, Marlys H. Witte	9
15	Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival 2020 ·Clinical Cancer Research ·Jung S. Byun, Sandeep K. Singhal, (unknown), (unknown), (unknown), (unknown), Alana Jones, Partha Mukhopadhyay, Sara M. Gil, Stephen M. Hewitt, Lisa A. Newman, Melissa B. Davis, Brittany D. Jenkins, Jorge L. Sepulveda, Adriana De Siervi, Anna María Nápoles, Nasreen A. Vohra, Kevin Gardner	17
16	Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes 2020 ·Cancer Letters ·(unknown), (unknown), (unknown), (unknown), Melissa B. Davis, Andrea Loaiza‐Perez, Eileen Brantley	9
17	Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells 2017 ·Scientific Reports ·(unknown), Shalini Srivastava, Melissa B. Davis, (unknown), Dulal Panda	59
18	Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1) / Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele 2015 ·PLoS ONE ·Melissa B. Davis, Andrea Walens, (unknown), (unknown), Andrea M. Brown, (unknown), Elizabeth W. Howerth, Michèle Monteil	16
19	Phenotypic analysis of EcR-A mutants suggests that EcR isoforms have unique functions during Drosophila development 2005 ·Developmental Biology ·Melissa B. Davis, Ginger E. Carney, A.E. Robertson, Michael Bender	77
20	Recent advances in Drosophila genomics. 2004 ·Genome Biology ·Melissa B. Davis, Kevin P. White	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact